6
Jul 2026
Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI
Research led by Professor Hodson-Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.
6
Jul 2026
Research led by Professor Hodson-Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.
6
Jul 2026
A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the stage of Huntington's disease.
6
Jul 2026
ReproNovo, a clinical-stage biopharmaceutical company committed to addressing critical gaps in male and female fertility as well as women’s health, today announced that the first participant has been dosed in the Company’s EU Phase 2 clinical trial of RPN-002, entitled Nolasiban Optimized Regimen Dosing for Inhibition of Uterine Contractility (NORDIC).
6
Jul 2026
Professor Stephen Euston and Dr. Hector Mora Gallego from the School of Engineering and Physical Sciences are working with industry collaborators New Food Innovation and AB Mauri, to develop a new way to cut the saturated fat in the layered dough used in sausage rolls.
6
Jul 2026
When watching a drama, we quickly learn who is friends with whom–and, just as importantly, who stands against whom.
6
Jul 2026
New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine - which is delivered through the skin to prevent tuberculosis - may remodel the human brain's immune environment, offering a potential biological explanation for previously observed associations between BCG vaccination and lower Alzheimer's disease risk.
6
Jul 2026
We are pleased to announce that, as of June 25, 2026, NKT Photonics has become the Lasers & Fibers Business Unit within the Hamamatsu Photonics Group and has been renamed Hamamatsu Photonics A/S.
6
Jul 2026
A study reveals narrowing gaps in blood pressure and cholesterol between obesity and normal BMI, highlighting evolving cardiometabolic risks over three decades.
6
Jul 2026
MGI Tech showcases cutting-edge laboratory automation solutions at SLAS 2026, enhancing research efficiency and simplifying complex workflows in life sciences.
6
Jul 2026
At ESHG 2026, MGI Tech presents cutting-edge genomics solutions, emphasizing automation and partnerships to enhance clinical workflows and precision medicine.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more